Circulating NK cells from SSc patients exhibited decreased expression of CX3CR1 (fractalkine receptor), and CXCR4 (SDF-1 receptor) chemokine receptors, as well as of the NKG2D activating receptor and CD69 activation marker. Here, CXCR4 is linked to systemic sclerosis.